Document Detail

Clinical predictors of outcome in vitiligo.
MedLine Citation:
PMID:  17656989     Owner:  NLM     Status:  PubMed-not-MEDLINE    
The significant inter-patient variability in progression, and response to therapy makes it a great challenge for the physician to predict the outcome of vitiligo at the very outset. Subjective factors like stress, pregnancy, sunburn and illness have been identified as aggravating factors for vitiligo. However, a few studies have evaluated the statistical significance of objective clinical parameters in predicting the outcome of vitiligo. Our retrospective analysis of 199 consecutive patients with vitiligo who presented to our OPD was aimed at evaluation of these objective clinical parameters utilizing a standard proforma. Patients already on treatment, and those with duration of disease less than 6 months were excluded from the study. Progression was defined as an increase in size or number of lesions in the 3 months prior to presentation. In all 76.9% patients had progression of vitiligo. The clinical parameters significantly associated with progression were a positive family history (p=0.027), mucosal involvement (p=0.032), Koebner's phenomenon (p=0.036) and nonsegmental vitiligo (p=0.033). Thrichrome sign, leucotrichia, longer duration and higher age at onset did not correlate significantly with progression. The one significant observation that we found to have the poor prognostic implication in vitiligo is the presence of mucosal vitiligo. The clinical prediction of disease progression at the outset enables the physician to set realistic treatment goals and optimize the therapeutic regimen for the individual patient.
Shriya Dave; Devinder Mohan Thappa; Mariette Dsouza
Related Documents :
7798429 - Nodulocystic acne: oral gugulipid versus tetracycline.
10230579 - Risk of melanoma with psoralen/ultraviolet a therapy for psoriasis. do the known risks ...
18229519 - Anogenital pruritus: lichen sclerosus in children.
9581579 - Topical psoralen-ultraviolet a therapy for palmoplantar dermatoses: experience with 35 ...
17324829 - Topical pimecrolimus in the treatment of vitiligo.
25055149 - Impact of intraoperative topical hydroxypropyl methylcellulose 2% versus sodium hyaluro...
20673139 - Treatment of oral florid papillomatosis with systemic administration of photocarcinorin...
9355229 - Management of flatback and related kyphotic decompensation syndromes.
7798429 - Nodulocystic acne: oral gugulipid versus tetracycline.
Publication Detail:
Type:  Journal Article    
Journal Detail:
Title:  Indian journal of dermatology, venereology and leprology     Volume:  68     ISSN:  0973-3922     ISO Abbreviation:  Indian J Dermatol Venereol Leprol     Publication Date:    2002 Nov-Dec
Date Detail:
Created Date:  2007-07-27     Completed Date:  2007-08-02     Revised Date:  -    
Medline Journal Info:
Nlm Unique ID:  7701852     Medline TA:  Indian J Dermatol Venereol Leprol     Country:  India    
Other Details:
Languages:  eng     Pagination:  323-5     Citation Subset:  -    
Department of Dermatology and STD, Jawaharlal Institute of Postgraduate Medical Education and Research, Pondicherry-605 006, India.
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine

Previous Document:  Hypereosinophilic syndrome.
Next Document:  Onychomycosis: a significant medical problem.